Skip to main content
Signal8

Lunai Bioworks Inc. (LNAI) Form 8-K — Nov 12, 2026

$LNAIForm 8-KItems 5.02, 9.01Filed Nov 12, 2026, 5:17 PM ET0001731122-26-001434Original filing

Lunai Bioworks voluntarily filed a Form 25 on November 2, 2026 to delist its common stock (LNAI) from Nasdaq, with the delisting expected effective on or about November 12, 2026 and deregistration following 90 days later. In the same filing, CEO David Weinstein signed an Amended and Restated Employment Agreement cutting his base salary from $400,000 to $275,000, making employment at-will and ending it December 28, 2026 unless extended, with no bonus or equity awards absent board approval.

Key figures

Ceo salary new
$275,000
Ceo salary prior
$400,000
Waived severance
approximately $200,000
Employment end date
December 28, 2026
Deferred salary payment
$28,150.68
Deregistration effective
90 days after November 2, 2026 Form 25 filing

AI analysis

Red flags4 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    Lunai Bioworks Inc. (LNAI) Form 8-K — Nov 12, 2026: AI Analysis | Signal8